Systematic review and meta-analysis of segmentectomy vs. lobectomy for stage IA non-small cell lung cancer
Authors:
Open Access
- 1 August 2023
- journal article
- review article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (8) , 4292-4305
Abstract
Background: Whether segmentectomy is appropriate for stage IA non-small cell lung cancer (NSCLC), especially for stage IA NSCLC with a tumor size of 2–3 cm, remains controversial. Thus, we conducted this meta-analysis to compare segmentectomy and lobectomy for stage IA NSCLC with a tumor size of 2–3 cm and IA ≤2 cm NSCLC. Methods: A systematic screening of online databases (PubMed, Embase, Web of Science, and Cochrane Library) was conducted regarding the terms of perioperative outcomes, overall survival (OS), recurrence-free survival (RFS), and disease-free survival (DFS). The inverse-variance and Mantel-Haenszel approaches were used to pool effect sizes for survival outcomes and perioperative outcomes. Results: A total of 10 articles were included in the analysis. The perioperative morbidity [risk ratio (RR): 0.90, P=0.10], mortality (RR: 0.94, P=0.84), intraoperative blood loss [mean difference (MD): 3.07, P=0.86] and operative time (MD: 18.99, P=0.13) were comparable between the segmentectomy and lobectomy groups. The number of lymph nodes harvested was statistically less in segmentectomy than in lobectomy (MD: −5.71, P=0.02). In stage IA patients with a tumor size of 2–3 cm, lobectomy showed superior survival outcomes compared to segmentectomy, with a pooled hazard ratio (HR) of 1.39 (P=0.01) for OS and 1.38 (P=0.06) for RFS or DFS. In stage IA ≤2 cm, lobectomy and segmentectomy had comparable survival outcomes with pooled HRs of 1.18 (P=0.29) for OS and 1.18 (P=0.12) for RFS or DFS. Conclusions: When a patient is in stage IA and the tumor size is less than 2 cm, segmentectomy should be performed. If the tumor size is between 2 and 3 cm, lobectomy is recommended.Keywords
This publication has 38 references indexed in Scilit:
- Segmentectomy or lobectomy for early stage lung cancer: a meta-analysisEuropean Journal of Cardio-Thoracic Surgery, 2013
- Survival After Segmentectomy and Wedge Resection in Stage I Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2013
- Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experienceEuropean Journal of Cardio-Thoracic Surgery, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Sublobectomy Versus Lobectomy for Stage I Non-Small-Cell Lung Cancer, A Meta-Analysis of Published StudiesAnnals of Surgical Oncology, 2011
- Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections☆European Journal of Cardio-Thoracic Surgery, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter studyThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Segmental resection spares pulmonary function in patients with stage I lung cancerThe Annals of Thoracic Surgery, 2004
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1995